← All companies ← INDI Manual INGM → ← INCR Pharmaceuticals INSM →
INDV, Indivior Pharmaceuticals Inc.
A pharmaceutical business, where patents grant a temporary monopoly the pipeline must keep refilling.
The business
What it sells, where the money comes from, the kind of company it is.
Next report Est. 10/27–11/4 · the 10-Q for the quarter ended late September · due within 40 days of period end · has filed ~31 days after · the wire records it on arrival
The business in brief
read the 10-K →What this business is and what moves its needle, from its own SEC filings.
- What moves the needle
- Operating margin has reached 21% at its best but run negative through the cycle (median −2.9%) on a 82% gross margin — so the question is which reading is truer: whether the median was pulled below zero by one-off charges, by the cycle, or by spending it is still growing into, and whether it settles back at a profit. Inventory runs near 12% of sales, so how fast it turns back into cash — and the risk of writing it down when demand softens — sits alongside the margin. Read this kind of business on the pipeline against the patent cliff, and pricing. On its own account, the filing leans hardest on pricing power & competition, set against the numbers in what the filing emphasizes, below.
Every line is arithmetic on the company's filings, shown in full in the sections below.
The record
Ten years of arithmetic, read across the cycle.
The record, 2022–2025
realized figures from each filing · older years to the left| 2022’22 | 2023’23 | 2024’24 | 2025’25 | TTMTTMJun 2026 | |
|---|---|---|---|---|---|
| Income statement | |||||
| $901M | $1.1B | $1.2B | $1.2B | $1.3B | RevenueRevenue |
| $749M | $919M | $957M | $994M | $1.1B | Gross profitGross prof. |
| 83% | 84% | 81% | 80% | 82% | Gross marginGross mgn |
| 52% | 52% | 52% | 51% | 44% | SG&A / revenueSG&A/rev |
| 8% | 11% | 9% | 8% | 6% | R&D / revenueR&D/rev |
| ($81M) | ($152M) | $38M | $262M | $421M | Operating incomeOp. inc. |
| −9.0% | −13.9% | 3.2% | 21.1% | 31.6% | Operating marginOp. mgn |
| ($89M) | ($145M) | $20M | $239M | — | Pretax incomePretax |
| ($44M) | ($126M) | $7M | $210M | $356M | Net incomeNet inc. |
| — | — | — | 12% | 10% | Effective tax rateTax rate |
| Cash flow & returns | |||||
| ($4M) | ($300M) | $36M | ($27M) | ($40M) | Operating cash flowOp. cash |
| $16M | $15M | $16M | $10M | $9M | Depreciation & amortizationD&A |
| $8M | ($210M) | ($11M) | ($273M) | ($437M) | Working capital & otherWC & other |
| $5M | $8M | $29M | $66M | $71M | CapexCapex |
| 0.6% | 0.7% | 2.4% | 5.3% | 5.3% | Capex / revenueCapex/rev |
| ($9M) | ($308M) | $20M | ($37M) | ($49M) | Owner earningsOwner earn. |
| −1.0% | −28.2% | 1.7% | −3.0% | −3.7% | Owner earnings marginOE mgn |
| ($9M) | ($308M) | $7M | ($93M) | ($111M) | Free cash flowFCF |
| −1.0% | −28.2% | 0.6% | −7.5% | −8.3% | Free cash flow marginFCF mgn |
| $0 | $129M | $0 | $0 | $0 | AcquisitionsAcquis. |
| $90M | $33M | $173M | $11M | — | BuybacksBuybacks |
| ($222M) | ($95M) | $69M | ($66M) | — | Investing cash flowInv. cash |
| ($101M) | ($64M) | ($102M) | ($30M) | — | Financing cash flowFin. cash |
| ($1M) | $1M | $0 | ($1M) | — | Exchange-rate effectFX |
| ($328M) | ($458M) | $3M | — | — | Change in cashΔ cash |
| Balance sheet | |||||
| $774M | $410M | $320M | $195M | $222M | Cash & investmentsCash+inv |
| — | $254M | $254M | $253M | $271M | ReceivablesReceiv. |
| — | $126M | $167M | $153M | $150M | InventoryInvent. |
| — | $39M | $63M | $48M | $30M | Accounts payablePayables |
| — | $341M | $358M | $358M | $391M | Operating working capitalOper. WC |
| — | $1.3B | $827M | $652M | $725M | Current assetsCur. assets |
| — | $1.3B | $924M | $914M | $868M | Current liabilitiesCur. liab. |
| — | 1.0× | 0.9× | 0.7× | 0.8× | Current ratioCurr. ratio |
| — | $84M | $100M | $144M | — | Net PP&ENet PP&E |
| — | $5M | $2M | $2M | $2M | GoodwillGoodwill |
| — | $1.8B | $1.3B | $1.2B | $1.2B | Total assetsAssets |
| — | $240M | $333M | $319M | $487M | Total debtDebt |
| — | ($170M) | $13M | $124M | $265M | Net debt / (cash)Net debt |
| -3.0× | -4.3× | 0.9× | 5.8× | 15.6× | Interest coverageInt. cov. |
| — | $1.9B | $1.7B | $1.3B | — | Total liabilitiesTotal liab. |
| ($15M) | ($184M) | ($337M) | ($98M) | ($208M) | Shareholders’ equityEquity |
| 1.8% | 1.9% | 2.0% | 2.1% | 2.4% | Stock comp / revenueSBC/rev |
| Per share | |||||
| 139M | 137M | 133M | 128M | 127M | Shares out (diluted)Shares |
| $6.48 | $7.98 | $8.93 | $9.68 | $10.48 | Revenue / shareRev/sh |
| $-0.32 | $-0.92 | $0.05 | $1.64 | $2.80 | EPS (diluted)EPS |
| $-0.06 | $-2.25 | $0.15 | $-0.29 | $-0.39 | Owner earnings / shareOE/sh |
| $-0.06 | $-2.25 | $0.05 | $-0.73 | $-0.87 | Free cash flow / shareFCF/sh |
| $0.04 | $0.06 | $0.22 | $0.52 | $0.56 | Cap. spending / shareCapex/sh |
| $-0.11 | $-1.34 | $-2.53 | $-0.77 | $-1.64 | Book value / shareBVPS |
| 3-yr | 5-yr | |
|---|---|---|
| Revenue / share | +14.3%/yr | +14.3%/yr (3-yr) |
| Capital spending / share | +142.9%/yr | +142.9%/yr (3-yr) |
Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.
In fiscal 2025 the business earned ($37M) of owner earnings, the operating cash left after the $10M it takes just to hold its position. It put $56M more into growth; free cash flow, after that spending, was ($93M).
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Reported net income | $210M | $7M | ($126M) | ($44M) |
| Depreciation & amortizationnon-cash charge added back | +$10M | +$16M | +$15M | +$16M |
| Stock-based compensationreal costnon-cash, but a real cost | +$26M | +$24M | +$21M | +$16M |
| Working capital & othertiming of cash in and out, other non-cash items | −$273M | −$11M | −$210M | +$8M |
| Cash from operations | ($27M) | $36M | ($300M) | ($4M) |
| Maintenance capital expenditurethe spending needed just to hold position and volume | −$10M | −$16M | −$8M | −$5M |
| Owner earnings | ($37M) | $20M | ($308M) | ($9M) |
| Growth capital expenditurediscretionary; spent to get bigger, not to stand still | −$56M | −$13M | — | — |
| Free cash flow | ($93M) | $7M | ($308M) | ($9M) |
| Owner-earnings marginowner earnings ÷ revenue | -3% | 2% | -28% | -1% |
Owner earnings is the cash an owner could pull out without starving the business: operating cash less the maintenance capital it must spend to hold its position (here about $10M, roughly its depreciation, the rate its assets wear out). The other $56M of its capital spending is growth it chose, not upkeep it owed; charged only with the maintenance it must do, the business earns well more than the year's free cash flow shows. The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $26M), owner earnings is nearer ($63M).
Much of fiscal 2025's profit didn't arrive as operating cash; it sits in “working capital & other” above. That can be a real inventory or timing swing, or profit that doesn't run through operating cash at all: a heavy tax year, equity-method earnings, or investment income booked through investing. For a year like this, owner earnings understates the cash earned; the full cash-flow statement carries the rest.
Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.
Quality & stewardship
Returns, the balance sheet, capital allocation, and pay.
Owner’s Scorecard
Will it survive?
- ComfortableOperating income $262M ÷ interest expense $45M
What this means
Operating profit covers interest with the kind of margin Graham wanted for a defensive holding. Necessary, not sufficient, it says solvent, not cheap.
- How heavy is the debt, net of cash? $124M · 0.5× operating profitModest net debtCash $195M − debt $319M
What this means
Netting $195M of cash and short-term investments against $319M of debt leaves $124M owed, about 0.5× a year's operating profit (1.2× on the gross debt, before the cash). Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.
- Long (60+ days)DSO 75 + DIO 227 − DPO 71 days
What this means
Days cash is tied up between paying suppliers and collecting from customers. Lower is better; a long cycle means growth itself eats cash.
Is it a good business?
- Not enough dataIndustry peers: median -7%
What this means
The filing data didn't include the inputs for this check.
- Consumes cash through the cycle4-yr median margin, range -28%–2%; latest ($37M) = operating cash ($27M) − maintenance capex $10MIndustry peers: median -1%
What this means
What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's -3% of revenue this year, a -2% median across 4 years. It chose to put $56M more into growth, so free cash flow this year was ($93M) — the gap is investment, not weakness. Treating stock comp as the real expense it is (less $26M of SBC) leaves ($63M).
- Are earnings backed by cash? -0.13×Thinly cash-backedCash from ops ($27M) ÷ net income $210M
In the filing’s words Read against the cash, reported earnings have run ahead of the operating cash the business generated over the record — about 10% of assets a year, among the widest gaps in the catalogue, and a manipulation screen of eight balance-sheet ratios trips here too. For an inventory- or content-heavy grower that can be cash tied up in real assets as it expands; elsewhere it can mean the earnings lean on accounting estimates — the cash-flow statement against the income statement is where to tell which.
What this means
How much of reported profit showed up as operating cash. Above 1× is reassuring; well below suggests earnings lean on accruals. One year is noisy, growth and working-capital swings distort it, and this is operating cash, not free cash. Watch the multi-year trend.
How is the cash used?
- No surplus to allocate
What this means
The business didn't generate positive Owner Earnings this year, so any distributions came from the balance sheet or borrowing, not from operations.
- Investing or harvesting? 6.60×ExpandingCapex $66M ÷ depreciation & amortization as filed $10M
What this means
Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.
The promise and the pay packet
- Is the buyback buying ownership, or mopping up? 2.1%The count is genuinely shrinkingStock compensation $26M (fiscal 2025), 2.1% of revenue · repurchases $11M · diluted shares -7.9% since 2022
What this means
Stock handed to employees is a real cost paid in the owner's own currency: it is charged against profit, but the shares it creates are permanent. Many companies repurchase stock at the same time, which looks like a return of capital and often is not — if the count barely moves, the cash merely cancelled the pay packet and bought the owner nothing. The three states worth telling apart are a count genuinely shrinking, a count standing still despite large repurchases, and a count rising because the issuance was never offset at all.
Graham’s defensive tests · 0 of 3 met
Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.
- Adequate size NearRevenue ≥ $2B · $1.2B
What this means
Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.
- Strong liquidity MissCurrent ratio ≥ 2× · 0.71×
What this means
Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.
- Conservative debt MissDebt ≤ working capital · $319M vs ($262M) WC
What this means
Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.
- Moderate price —P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
What this means
Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $0.26/share (latest year $1.78), the averaged base the calculator's gate runs on, and book value is $-0.83/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.
Durability & moat, 2022–2025
Whether the record’s returns held, and what the capital reinvested earned.
- Profitable years 2 of 4
What this means
Lost money in 2 year(s), look at what happened there before trusting the average.
- Operating margin −11% → 12% (2-yr avg ends)
In the filing’s words The record and the words agree: the margin widened and the filing attributes the gain to its own pricing, not volume alone.
What this means
Through the cycle the operating margin widened — about −11% early to 12% lately, median −9% — pricing power intact or improving.
- Reinvestment, incremental ROIC returns capital
What this means
The capital base barely grew: this business returns cash through dividends and buybacks rather than reinvesting. Judge it on the cash returned, not on compounding.
- Worst year 2023 · −13.9% op. margin
What this means
Operations went underwater in 2023, understand why before trusting the good years.
- Share count −2.7%/yr
What this means
The share count is shrinking, buybacks are quietly growing your slice of the business.
- How management talks about it Promotional
What this means
The record is compounding, but the filing leans on a promoter’s vocabulary rather than the per-share, return-on-capital terms an owner uses. The results back the talk here; the register is still worth noting.
All figures as filed; the source filing is linked above.
Current Position
as of the latest quarter, Jun 30, 2026Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.
- Cash & short-term investments$222M
- Receivables$271M
- Inventory$150M
- Other current assets$82M
- Accounts payable$30M
- Other current liabilities$838M
From the company's latest filing.
Management, ownership & pay
read the proxy →From the proxy: how much of the business the people running it own, and how they are paid, beside what the business earned for its owners in the same years.
| Fiscal year | Chief executive | Pay, as filed | “Actually paid” | Owner earnings |
|---|---|---|---|---|
| 2023 | Mark Crossley | $4.4M | −$5.5M | ($308M) |
| 2024 | Mark Crossley | $3.9M | $1.2M | $20M |
| 2025 | Joe Ciaffoni | $18.5M | $63.3M | ($37M) |
| 2025 | Mark Crossley | $3.2M | $19.3M | ($37M) |
Both pay figures are the company’s own, from the pay-versus-performance table its proxy statement files. “As filed” is the Summary Compensation Table total: salary, bonus, and equity awards at their value on the day of grant. “Actually paid” is the SEC’s prescribed recalculation, which re-marks those equity awards to what they became as they vested; it can swing far above or below the filed figure in either direction, and negative years occur. Owner earnings are the whole business's, from the record above, for the same fiscal years.
- Insider ownership<1%
The stake all directors and executive officers hold together, per the 2026 proxy: skin in the game, the first thing Munger reads.
- Stock-based compensation$26M
The slice of the business handed to employees in shares in fiscal 2025, 2.1% of revenue, equal to 9.9% of operating profit. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.
Peers, Pharmaceuticals
The same industry, side by side on owner economics. Each column names the period it is read over, and a median resting on fewer than three years carries that count beside it; the group median at the foot is the line to read each figure against.
| Company | Revenuelatest FY, USD | Gross marginmedian over the record | Op. marginmedian over the record | ROICmedian over the record | Owner earn. marginmedian over the record |
|---|---|---|---|---|---|
| ALKSAlkermes | $1.5B | 84% | -4.8% | -7% | 3% |
| PAHCPhibro Animal Health Corporation | $1.3B | 32% | 8.8% | 16% | 3% |
| LKFTLakefront Biotherapeutics | $1.3B | 92%2y | -37.1% | -6% | -106% |
| INDVIndivior Pharmaceuticals Inc. | $1.2B | 82% | -2.9% | — | -2% |
| ENLVEnlivex Ltd. | $1.2B | — | -1.2%1y | -62% | -1%1y |
| PBHPrestige Consumer Healthcare | $1.1B | 56% | 29.0% | 8% | 21% |
| ACADACADIA Pharmaceuticals Inc. | $1.1B | 94% | -43.2% | -48% | -26% |
| LEGNLegend Biotech Corporation | $1.0B | 55% | -198.6% | -125% | -143% |
| Group median | — | 82% | -3.8% | — | -1% |
The price
What a price has to assume.
What the price implies
reverse-DCFIndivior Pharmaceuticals Inc. is profitable, but owner earnings are negative this year because capital spending currently outruns operating cash, a build-out, so the owner-earnings reverse-DCF has no positive base to grow. We read the price from both ends instead: type a price to see the steady-state profitability it demands, then set the mature margin you would believe and weigh the two against each other. Nothing leaves your browser unless you enter it in your notebook.
Revenue, delivered11%/yr’22→’25
Enter a price to run it.
A dated snapshot of the price you typed, the assumptions you set, and what the page showed for them. A snapshot is never edited after it is saved. Your notebook is yours alone — the commitment states what is stored and what we will never do.
Two reads of one future. From your price: the owner earnings the company must reach, valued at a mature multiple and discounted back at your rate, expressed as the margin it implies on revenue grown at your rate. From your belief: the mature margin you would credit, set on the dial above. When the margin the price demands runs above the one you would believe, you are paying for a future taken on faith. For a deep cyclical at a trough, normalized through-cycle earnings are the better lens; this mode is for the genuinely unprofitable, and for the profitable business whose capital spending currently outruns its cash.
Manual order: ← INDI its page in the Manual INGM →
Industry order: ← INCR the Pharmaceuticals chapter INSM →